QQ客服 官方微博 反馈留言

	Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis
	Dong, Yidian; Li, Ping; Xu, Tingshuang; Bi, Liqi
刊名	CLINICAL RHEUMATOLOGY
	2019
卷号	38期号:6
关键词	Ankylosing spondylitis Biological therapy Drug monitoring Etanercept Pharmacokinetics
ISSN号	0770-3198
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3512142
专题	吉林大学白求恩第三医院
推荐引用方式 GB/T 7714	Dong, Yidian,Li, Ping,Xu, Tingshuang,et al. Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis[J]. CLINICAL RHEUMATOLOGY,2019,38(6).
APA	Dong, Yidian,Li, Ping,Xu, Tingshuang,&Bi, Liqi.(2019).Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis.CLINICAL RHEUMATOLOGY,38(6).
MLA	Dong, Yidian,et al."Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis".CLINICAL RHEUMATOLOGY 38.6(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。